Methylphenidate improves cognitive deficits produced by infantile iron deficiency in rats

Behavioural Brain Research
Wael M Y MohamedByron C Jones

Abstract

In humans, iron deficiency early in life produces persistent, impaired cognition. Dietary iron replacement does not ameliorate these problems and to date, no attempt to treat these individuals pharmacologically has been reported. The aim of this work was to test the hypothesis that rats made iron deficient in early infancy exhibit cognitive deficits similar to those seen in humans at adolescence. A second aim was to investigate whether the deficit could be treated pharmacologically. Sprague-Dawley rats were made iron deficient (ID) starting at postnatal day 4 by being placed with iron-deficient dams (vs. control). At weaning, all pups were placed on an iron-sufficient diet for the remainder of the study. At 45 days of age, the animals were tested for attention set shifting. After testing, the animals were assigned to one of three methylphenidate (MePh) dose groups, 1, 5 or 10 mg/kg, p.o., vs. vehicle control and treated daily for 15 days prior to a second round of attention set shift testing and continued throughout testing. The results showed that ID rats performed more poorly than controls overall on attentional set-shift testing. MePh improved ID rats' performance and lower doses were more effective than higher doses. This i...Continue Reading

References

Mar 1, 1979·Early Human Development·J Dobbing, J Sands
Sep 1, 1972·Journal of Experimental Psychology·H H KendlerJ W Ward
Mar 26, 1997·JAMA : the Journal of the American Medical Association·A C LookerC L Johnson
Mar 2, 1999·Nature·E R WoodH Eichenbaum
Oct 12, 1999·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·D M MontagueJ H Gilmore
Mar 10, 2000·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·F I Tarazi, R J Baldessarini
Aug 18, 2001·Pharmacology, Biochemistry, and Behavior·K M EriksonJ L Beard
Sep 15, 2001·Brain Research. Developmental Brain Research·B Kolb, J Cioe
Jul 20, 2002·Progress in Neurobiology·André Nieoullon
Sep 6, 2002·Pharmacology, Biochemistry, and Behavior·Byron C JonesPatricia Sue Grigson
Dec 4, 2003·Behavioural Brain Research·Kerry McAlonan, Verity J Brown
Dec 23, 2003·The European Journal of Neuroscience·Michelle M Nicolle, Mark G Baxter
Dec 8, 2004·Archives of Pediatrics & Adolescent Medicine·Eric KonofalMarie-Christine Mouren
Jun 14, 2005·Biological Psychiatry·Joseph Biederman
Mar 30, 2006·Behavioural Brain Research·John L BeardMichael K Georgieff
Jun 15, 2006·Nutrition Reviews·Betsy LozoffTimothy Schallert
Nov 15, 2006·Seminars in Pediatric Neurology·Betsy Lozoff, Michael K Georgieff
Mar 28, 2008·Journal of Neurochemistry·Laura E BiancoJohn L Beard
Dec 30, 2008·Neuroscience and Biobehavioral Reviews·Andrew Holmes, Cara L Wellman
May 30, 2009·Pharmacotherapy·Julie A Dopheide, Steven R Pliszka
Jul 1, 2005·Indian Journal of Clinical Biochemistry : IJCB·Jyoti Batra, Archana Sood

❮ Previous
Next ❯

Citations

Mar 14, 2013·Journal of Child and Adolescent Psychopharmacology·Chadi Albert Calarge, Ekhard E Ziegler
Feb 20, 2016·Journal of Child and Adolescent Psychopharmacology·Chadi A CalargeL Eugene Arnold
Nov 10, 2016·Ageing Research Reviews·Pu Wang, Zhan-You Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.